The DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
SOCS3, a Major Regulator of Infection and Inflammation
Open accessAbstract
In this review, we describe the role of suppressor of cytokine signaling-3 (SOCS3) in modulating the outcome of infections and autoimmune diseases as well as the underlying mechanisms. SOCS3 regulates cytokine or hormone signaling usually preventing, but in some cases aggravating, a variety of diseases. A main role of SOCS3 results from its binding to both the JAK kinase and the cytokine receptor, which results in the inhibition of STAT3 activation. Available data also indicate that SOCS3 can regulate signaling via other STATs than STAT3 and also controls cellular pathways unrelated to STAT activation. SOCS3 might either act directly by hampering JAK activation or by mediating the ubiquitination and subsequent proteasome degradation of the cytokine/growth factor/hormone receptor. Inflammation and infection stimulate SOCS3 expression in different myeloid and lymphoid cell populations as well as in diverse non-hematopoietic cells. The accumulated data suggest a relevant program coordinated by SOCS3 in different cell populations, devoted to the control of immune homeostasis in physiological and pathological conditions such as infection and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC5 promotes the upregulation of Chemokine ligand 2 (CCL2) by inhibiting SOCS3, thereby recruiting CCR2+ macrophages [147].”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.013 · Cited by 96
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Binding to the cytokine activates the kinase function of JAK, a tyrosine kinase that binds to the receptor, which auto-phosphorylates itself, cross-phosphorylates a JAK molecule bound to the accompanying heterodimer chain of the cytokine receptor and also different tyrosine sites on the cytokine receptor (1).”
BackgroundNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 4×
“SOCS3 has been also suggested to inhibit IL-12-induced STAT4 activation by direct binding to IL-12Rβ2 (37), the IL-12R subunit that is not shared with the IL-23R.”
BackgroundInfluentialJournal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,427
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Flagged first, then by citations
1 of the 179 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106939 · Cited by 397
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases
WHI-EMPC Investigators, Ligthart, S., Disease, C. E. O. C. H., Marzi, C., Aslibekyan, S. W., Mendelson, M., Conneely, K. N., Tanaka, T., Colicino, E., Waite, L. L., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1119-5 · Cited by 317
“The gene product of SOCS3, suppressor of cytokine signaling 3, plays a pivotal role in the innate immune system as a regulator of cytokine signaling [11].”
BackgroundT cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 327
Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
Sousa, C., Golebiewska, A., Poovathingal, S. K., Kaoma, T., Pires‐Afonso, Y., Martina, S., Coowar, D., Azuaje, F., Skupin, A., Balling, R., et al. (2018) · The EMBO Reports · doi:10.15252/embr.201846171 · Cited by 281
“Specifically, STAT3 and suppressor of cytokine signalling 3 (SOCS3) regulate inflammatory responses [54].”
Estrogen Receptor Signaling in the Immune System
Chakraborty, B., Byemerwa, J. K., Krebs, T., Lim, F., Chang, C., & McDonnell, D. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac017 · Cited by 283
Chen, H.-M., van der Touw, W., Wang, Y. S., Kang, K., Mai, S., Zhang, J., Alsina‐Beauchamp, D., Duty, J. A., Mungamuri, S. K., Zhang, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97570 · Cited by 254
“The induction of SOCS3 could result from the anti-LILRB2–mediated release of proinflammatory cytokines (IL-6 and IL-12) through activation of MAPK/NF-κB cascades (57, 58).”
Genetic and epigenetic studies of atopic dermatitis
Bin, L., & Leung, D. Y. M. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0158-5 · Cited by 242
“Both suppressor of cytokine signaling 3 (SOCS3) and IL-10 can suppress adaptive immune responses [142, 143].”
BackgroundTargeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, C., Guan, X., Zhang, X., Luan, X., Song, Z., Cheng, X., Zhang, W., & Qin, J.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01629-2 · Cited by 231
“HDAC5 promotes the upregulation of Chemokine ligand 2 (CCL2) by inhibiting SOCS3, thereby recruiting CCR2+ macrophages [147].”
BackgroundBone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection
Askenase, M. H., Han, S., Byrd, A. L., da Fonseca, D. M., Bouladoux, N. J., Wilhelm, C., Konkel, J. E., Hand, T. W., Lacerda‐Queiroz, N., Su, X., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.011 · Cited by 223
“, 2008), and Socs3, which encodes a negative regulator of inflammatory cytokine signaling (Carow and Rottenberg, 2014), was also increased.”
JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Gotthardt, D., Trifinopoulos, J., Sexl, V., & Putz, E. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02590 · Cited by 224
“SOCS3 counteracts inflammation by inhibiting a variety of pro-inflammatory signaling pathways (202).”
BackgroundRole of interleukin-6 in cachexia
Narsale, A. A., & Carson, J. A. (2014) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000091 · Cited by 205
“STAT-3 phosphorylation leads to the transcription of suppressor of cytokine signaling 3 (SOCS-3) – a negative regulator of IL-6 signaling [18,19] (Fig.”
BackgroundDynamic control of type I IFN signalling by an integrated network of negative regulators
Porritt, R. A., & Hertzog, P. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.002 · Cited by 206
Salminen, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101573 · Cited by 207
“It is known that the SOCS3 protein controls many immune functions since it can induce a negative feedback response to the immune outcome mediated by several cytokines and hormones (Carow and Rottenberg, 2014).”
BackgroundProtective effect of suppressing STAT3 activity in LPS-induced acute lung injury
Zhao, J., Yu, H., Liu, Y., Gibson, S. A., Yan, Z., Xu, X., Gaggar, A., Li, P., Li, C., Wei, S., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00281.2016 · Cited by 182
“As a JAK-STAT3 inducible protein, suppressor of cytokine signaling-3 (SOCS3) regulates STAT3 activation via a negative feedback loop in macrophages (8, 15, 31, 51).”
Peng, Y., Zhao, J., Peng, Z., Xu, W., & Yu, G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2545-6 · Cited by 180
Detection of differentially abundant cell subpopulations in scRNA-seq data
Zhao, J., Jaffe, A., Li, H., Lindenbaum, O., Sefik, E., Jackson, R., Cheng, X., Flavell, R. A., & Kluger, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100293118 · Cited by 154
“…in moderate cases and is characterized by the expression of the inhibitory and anti-inflammatory gene IL1RN (32), as well as SOCS3 , an important regulator in restraining inflammation with previously characterized functions in regulating cytokine signaling and the subsequent response (33–35).”
BackgroundSOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer
Sobah, M. L., Liongue, C., & Ward, A. C. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.727987 · Cited by 177
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer
Hou, P., Kapoor, A., Zhang, Q., Li, J., Wu, C.-J., Li, J., Lan, Z., Tang, M., Ma, X., Ackroyd, J. J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0597 · Cited by 154
“Among the 306 top 5 candidates, we focused on Zfp36 and Socs3, because Zfp36 is known to promote AU-rich 307 mRNA decay including Ccl2 mRNA in macrophages(33), and SOCS3 is known to repress STAT 308 pathway activation (34) and negatively regulates IFNβ induced expression of Ccl2 and Cxcl10 in 309 primary astrocytes (3…”
BackgroundThe Ying and Yang of STAT3 in Human Disease
Vogel, T. P., Milner, J. D., & Cooper, M. A. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0187-8 · Cited by 166
“DNA binding motifs and intersecting negative feedback loops it follows that an increase or decrease in the activation status of one STAT molecule can lead to alterations in others, ultimately resulting in similar functional outcomes [2, 18, 23].”
BackgroundAn Update on the Multifaceted Roles of STAT3 in the Heart
Harhous, Z., Booz, G. W., Ovize, M., Bidaux, G., & Kurdi, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00150 · Cited by 145
“As already stated, STAT3 is acutely activated downstream of IL-6 via the gp-130 receptor, and this activation is regulated by subsequent inhibition by SOCS3 (179).”
BackgroundMicroglial phenotypes in the human epileptic temporal lobe
Morin‐Brureau, M., Milior, G., Royer, J., Chali, F., Duigou, C. L., Savary, E., Blugeon, C., Jourdren, L., Akbar, D., Dupont, S., et al. (2018) · Brain · doi:10.1093/brain/awy276 · Cited by 150
The roles of SOCS 3 and STAT 3 in bacterial infection and inflammatory diseases
Gao, Y., Zhao, H., Wang, P., Wang, J., & Zou, L. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12727 · Cited by 143
“inflammation and induce the first level of protective immune response in different mouse models.(13) This review examines the latest advances of understanding SOCS3 and STAT3 in different cell populations during immune response.”
BackgroundNew paradigms in sepsis: from prevention to protection of failing microcirculation
Hawiger, J., Veach, R. A., & Zienkiewicz, J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13061 · Cited by 140
Monocyte differentiation and macrophage polarization
Orekhov, A. N., Orekhova, V. A., Nikiforov, N. G., Myasoedova, V. A., Grechko, A. V., Romanenko, E. B., Zhang, D., & Chistiakov, D. A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.04 · Cited by 144
“Deficiency of STAT-3 in mice is characterized by impaired antimicrobial immune responses and increased release of pro-inflammatory cytokines and IL-10 in response to stimulation by LPS[73] suggesting an important role of STAT-3 in IL-10-mediated inhibition of inf lammation.”
BackgroundInfluentialNF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity
Ghislat, G., Cheema, A. S., Baudoin, E., Verthuy, C., Ballester, P. J., Crozat, K., Attaf, N., Dong, C., Milpied, P., MALISSEN, B., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg3570 · Cited by 131
Macrophage immunoregulatory pathways in tuberculosis
Rajaram, M. V. S., Ni, B., Dodd, C. E., & Schlesinger, L. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.010 · Cited by 131
“There is some evidence for their role in TB pathogenesis [49,76,174–178] (Fig.”
BackgroundProceedings of the 35th European Peptide Symposium
Bonnet, D. (2018) · doi:10.17952/35eps · Cited by 124
COVID-19 Sepsis and Microcirculation Dysfunction
Colantuoni, A., Martini, R., Caprari, P., Ballestri, M., Capecchi, P. L., Gnasso, A., Presti, R. L., Marcoccia, A., Rossi, M., & Caimi, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00747 · Cited by 130
“Activated neutrophils andmonocytes adhering to endothelial cells release reactive oxygen-derived free radicals that increase the damage to endothelium with impairment of endothelial barrier (Turer et al., 2008; Goldenberg et al., 2011; Hotchkiss et al., 2013; Carow and Rottenberg, 2014; Letsiou et al., 2015; Shalova e…”
BackgroundWoytschak, J., Keller, N., Krieg, C., Impellizzieri, D., Thompson, R. W., Wynn, T. A., Zinkernagel, A. S., & Boyman, O. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.025 · Cited by 128
“…both STAT3-dependent and STAT3-independent effects in neutrophils and also stimulated suppressor of cytokine signaling 3 (SOCS3), which in turn acts as an important negative feedback regulator of G-CSF receptor signaling by inhibiting STAT3 (Carow and Rottenberg, 2014; Nguyen-Jackson et al., 2010).”
BackgroundRodríguez-Giraldo, M., González-Reyes, R. E., Ramírez-Guerrero, S., Bonilla-Trilleras, C. E., Guardo-Maya, S., & Nava-Mesa, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113630 · Cited by 122
Sensory hair cell regeneration in the zebrafish lateral line
Lush, M. E., & Piotrowski, T. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24167 · Cited by 112
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13359 · Cited by 112
“SOCS3 is a cytokine signalling suppressor that can modulate the outcome of autoimmune diseases.([61]) When JAK/STAT pathway is upregulated in hypothalamus, an increase in SOCS3 amount could inhibit IRS/PI3K/Akt insulin signalling pathway and activate inflammatory response.”
BackgroundThe Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
Abaurrea, A., Araujo, A. M., & Caffarel, M. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158334 · Cited by 112
“STATs also induce the suppressors of cytokine signalling (SOCS) [37,38], which bind to tyrosine-phosphorylated JAK and tyrosine-phosphorylated gp130 [39], respectively, to stop IL-6 family signalling by means of a negative feedback loop.”
BackgroundSOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review
Duncan, S. A., Baganizi, D. R., Sahu, R., Singh, S. R., & Dennis, V. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02431 · Cited by 104
“The expression of SOCS2 increased in macrophages infected with mycobacteria, and SOCS2-deficient mice exhibited a higher sensitivity to the inflammation induced by M. bovis infection (Carow and Rottenberg, 2014).”
BackgroundScarano, A., Butelli, E., Santis, S. D., Cavalcanti, E., Hill, L. M., Angelis, M. D., Giovinazzo, G., Chieppa, M., Martin, C. R., & Santino, A. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00075 · Cited by 98
“These changes included the downregulation of SOCS3, a positive regulator of cytokine signaling (24), Muc1, whose overexpression is associated with IBD (25) and S100a8, a component of the calprotectin complex and a clinical marker for IBD (26) (Figure S8 in Supplementary Material).”
Adams, A. T., Kennedy, N. A., Hansen, R., Ventham, N. T., O’Leary, K. R., Drummond, H. E., Noble, C. L., El-Omar, E. M., Russell, R. K., Wilson, D. C., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000179 · Cited by 97
IL-10/STAT3/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole
Cevey, Á. C., Penas, F., Soto, C. D. A., Mirkin, G. A., & Goren, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01267 · Cited by 98
“SOCS3, one of the better studied members of the SOCS family, controls critical cellular processes such as cell growth, apoptosis, and transcription of inflammatory genes (38).”
BackgroundMeta-analysis of epigenome-wide association studies of cognitive abilities
Marioni, R. E., McRae, A. F., Bressler, J., Colicino, E., Hannon, E. J., Li, S., Prada, D., Smith, J. A., Trevisi, L., Tsai, P.-C., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0008-y · Cited by 87
“In the fully adjusted model, significant CpGs were located in genes associated with, for example: inflammation (SOCS3, Digit Test, cg18181703) [50], epithelial cell splicing (ESRP2, Vocabulary, cg04513006) [51] and transcription activation of NOTCH proteins (MAML3, Phonemic Verbal Fluency, cg16201957) [52].”
BackgroundSOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses
Huang, S., Liu, K., Cheng, A., Wang, M., Cui, M., Huang, J., Zhu, D., Chen, S., Liu, M., Zhao, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.558341 · Cited by 90
“It seems that the negative regulation of other cytokine pathways is the main role of SOCS3, such as the regulation of IL-6 family cytokine signaling (55), but it has also been shown that SOCS3 can inhibit the antiviral function of IFNs.”
BackgroundA macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury
Privratsky, J. R., Ide, S., Chen, Y., Kitai, H., Ren, J., Fradin, H., Lu, X., Souma, T., & Crowley, S. D. (2022) · Kidney International · doi:10.1016/j.kint.2022.10.008 · Cited by 87
Decoding the endometrial niche of Asherman’s Syndrome at single-cell resolution
Santamaría, X., Rosón, B., Pérez-Moraga, R., Venkatesan, N., Pardo‐Figuerez, M., González-Fernández, J., Llera-Oyola, J., Fernández, E., Moreno, I., Salumets, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41656-1 · Cited by 86
SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis
Rottenberg, M. E., & Carow, B. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.10.004 · Cited by 84
Self-citationThe importance of inflammation control for the treatment of chronic diabetic wounds
Worsley, A., Lui, D. H., Ntow‐Boahene, W., Song, W., Good, L., & Tsui, J. C. S. (2022) · International Wound Journal · doi:10.1111/iwj.14048 · Cited by 89
“Chronic hyperglycaemia has been shown to upregulate the signalling molecule suppressor of cytokine signalling 3 (SOCS3), a protein usually involved in the suppression of inflammation.(65) Surprisingly, in the diabetic chronic wound environment, this exacerbates wound inflammation.”
BackgroundSun, X., Hua, S., Chen, H.-R., Ouyang, Z., Einkauf, K. B., Tse, S. Y., Ard, K. L., Ciaranello, A. L., Yawetz, S., Sax, P. E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.087 · Cited by 82
“Remarkably, we noted that upregulation of AXL coincided with increased expression of SOCS3, consistent with mutuallyinterdependent interactions between members of the TAM signaling network and the suppressor of cytokine signaling (SOCS) family (Carow and Rottenberg, 2014).”
BackgroundInfluentialSenger, S., Ingano, L. A. M., Freire, R. H., Anselmo, A., Zhu, W., Sadreyev, R. I., Walker, W. A., & Fasano, A. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.014 · Cited by 78
Wang, X., Yang, C., Zhao, Y., Xu, Z., Yang, W. Z., Wang, P., Lin, D., Xiong, B., Fang, J., Dong, C., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0089-4 · Cited by 80
Hackett, A. R., Lee, D.-H., Dawood, A., Rodriguez, M., Funk, L. H., Tsoulfas, P., & Lee, J. K. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.017 · Cited by 79
“SOCS3 has also been implicated in regulating other signaling pathways, such as IGF1/insulin, and TNFα/NFκB (Rottenberg and Carow, 2014), both of which are pathways known to be activated after SCI.”
BackgroundIdentification of a transitional fibroblast function in very early rheumatoid arthritis
Filer, A. D., Ward, L. S. C., Kemble, S., Davies, C. S., Munir, H., Rogers, R., Raza, K., Buckley, C. D., Nash, G. B., & McGettrick, H. M. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211286 · Cited by 75
Vigors, S., O’Doherty, J. V., Kelly, A. K., O’Shea, C. J., & Sweeney, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148145 · Cited by 74
“One possible explanation is that the level of SOCS3 in the LRFI group is sufficient to reduce the levels of IL-6 whereas the HRFI group despite having increased SOCS3 are unable to regulate the expression of IL-6.”
BackgroundInfluentialMarech, I., Leporini, C., Ammendola, M., Porcelli, M., Gadaleta, C. D., Russo, E., Sarro, G. D., & Ranieri, G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.028 · Cited by 73
Signal transducer and activator of transcription 3
Forbes, L. R., Milner, J., & Haddad, É. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000206 · Cited by 69
Kahan, S. M., Bakshi, R. K., Ingram, J. T., Hendrickson, R. C., Lefkowitz, E. J., Crossman, D. K., Harrington, L. E., Weaver, C. T., & Zajac, A. J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl6322 · Cited by 67
Zhao, Y., Zhang, K., & Fent, K. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b03436 · Cited by 70
Harling, K., Adankwah, E., Güler, A., Awuah, A. A.-A., Adu-Amoah, L., Mayatepek, E., Owusu‐Dabo, E., Nausch, N., & Jacobsen, M. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2018.5 · Cited by 67
CDK6 Inhibition: A Novel Approach in AML Management
Uras, I. Z., Sexl, V., & Kollmann, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072528 · Cited by 65
Luo, Y., Fang, Y., Kang, R., Lenahan, C., Gamdzyk, M., Zhang, Z., Okada, T., Tang, J., Chen, S., & Zhang, J. H. (2020) · Stroke · doi:10.1161/strokeaha.120.029951 · Cited by 65
Agudelo, J. S. H., Braga, T. T., Amano, M. T., Cenedeze, M. A., Cavinato, R. A., dos Santos, A. R. P., Muscará, M. N., Teixeira, S. A., Cruz, M. C., Castoldi, Â., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00881 · Cited by 63
“The possible explanation for this molecular interplay would be the fact that SOCS3 is a strong inhibitor of the STAT6 signaling pathway, thus interfering with IL-6 expression, which seems to be regulated downstream by miR-155 (43).”
BackgroundRegulation of human interferon signaling by transposon exonization
Pasquesi, G. I. M., Allen, H. L., Ivancevic, A. M., Barbachano-Guerrero, A., Joyner, O., Guo, K., Simpson, D. M., Gapin, K., Horton, I., Nguyen, L. L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.11.016 · Cited by 67
Immunity and inflammation: the neglected key players in congenital heart disease?
Wienecke, L. M., Cohen, S., Bauersachs, J. K., Mebazaa, A., & Chousterman, B. G. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10187-6 · Cited by 69
“Hypoxia-induced SOCS3 expression can be stimulated by inflammation and infection and is involved in the myocardial adaptation to chronic hypoxia in CHD [20, 21].”
BackgroundDecoding inflammation, its causes, genomic responses, and emerging countermeasures
Hawiger, J., & Zienkiewicz, J. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12812 · Cited by 62
Al-Khazaleh, A. K., Zhou, X., Bhuyan, D. J., Münch, G. W., Al-Dalabeeh, E. A., Jaye, K. M., & Chang, D. (2024) · Molecules · doi:10.3390/molecules29020410 · Cited by 66
“NF-κ inflammation [93,94].”
Gaudio, N. D., Costanzo, A. D., Liu, N. Q., Conte, L., Migliaccio, A., Vermeulen, M., Martens, J. H. A., Stunnenberg, H. G., Nebbioso, A., & Altucci, L. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1570-9 · Cited by 61
EVs from BALF—Mediators of Inflammation and Potential Biomarkers in Lung Diseases
Zaręba, Ł., Szymański, J., Homoncik, Z., & Czystowska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073651 · Cited by 58
“EVs derived from AMs containing SOCS3 significantly restrained STAT3 activation and reduced proliferation and survival of lung adenocarcinoma cells.”
BackgroundInfluentialZheng, Y., Joyce, B. T., Hwang, S., Ma, J., Liu, L., Allen, N. B., Krefman, A. E., Wang, J., Gao, T., Nannini, D. R., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055484 · Cited by 59
Walker, D. G., Whetzel, A. M., & Lue, L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.052 · Cited by 57
“…(IL) and interferons (IFN), and growth factors exert their biological effects via the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathways following interactions with cell surface receptors (Carow and Rottenberg, 2014;Dimitriou et al, 2008;Kershaw et al, 2013).”
Comprehensive analysis of an lncRNA-miRNA-mRNA competing endogenous RNA network in pulpitis
Lei, F., Zhang, H., & Xie, X. (2019) · PeerJ · doi:10.7717/peerj.7135 · Cited by 55
Elhennawy, M. G., Abdelaleem, E. A., Zaki, A. A., & Mohamed, W. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22730 · Cited by 54
Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing
Dong, Y., Chen, J., Chen, Y., & Liu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115513 · Cited by 59
Macrophage polarization in response to oral commensals and pathogens
Huang, C. B., Alimova, Y. V., & Ebersole, J. L. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw011 · Cited by 51
“…negatively by guest on February 20, 2016 http://fem spd.oxfordjournals.org/ D ow nloaded from regulate cytokine signaling, and form part of a negative feedback loop for inflammation via STATs and NFB (Baetz, et al. 2007: 160-7, Carow and Rottenberg 2014: 58, Delgado-Ortega, et al. 2013: 1-19).”
BackgroundYan, Z., Yang, W., Parkitny, L., Gibson, S. A., Lee, K. S., Collins, F., Deshane, J. S., Cheng, W., Weinmann, A. S., Wei, H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126520 · Cited by 59
“SOCS3 negatively regulates STAT3 signaling and is induced upon activation of the JAK/STAT pathway (61).”
BackgroundHu, Y., Jiang, Y., Li, S., Ma, X., Chen, M., Yang, R., Wen, S., Moynagh, P. N., Wang, B., Hu, G., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210809119 · Cited by 51
Wu, R., Wang, C., Li, Z., Xiao, J., Li, C., Wang, X., Kong, P., Cao, J., Huang, F., Li, Z., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001037 · Cited by 52
“We found that SAHA could sensitize the melanoma cells to T-cell killing in IFN γ pretreated group (figure 4F, online supplemental figure 5D).”
Zhang, Y., Tao, G., Hu, L., Qu, J., Han, Y., Zhang, G., Qian, Y., Jiang, C., & Liu, W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0983-6 · Cited by 52
“hairpin RNAs, or cell-penetrating SOCS3 proteins have been performed [43].”
Poulsen, L. L. C., Englund, A. L. M., Wissing, M. L., Andersen, C. Y., Borup, R., & Grøndahl, M. L. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.02.014 · Cited by 52
Weathington, N. M., O’Brien, M. E., Radder, J. E., Whisenant, T. C., Bleecker, E. R., Busse, W. W., ERZURUM, S. C., Gaston, B. M., Hastie, A. T., Jarjour, N. N., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201811-2221oc · Cited by 49
Zhang, S., Ji, W.-W., Wei, W., Zhan, L., & Huang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04470-5 · Cited by 48
“Given that SOCS3 acts as a negative regulator of the JAK/STAT3 pathway [30, 31], we next assessed STAT3 activation.”
BackgroundNET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
Giusti, D., Bini, E. I., Terryn, C., Didier, K., Jan, S. L., Gatouillat, G., Durlach, A., Nesmond, S., Muller, C. B., Bernard, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00701 · Cited by 48
Epigenetics and Inflammatory Markers: A Systematic Review of the Current Evidence
González-Jaramillo, V., Portilla-Fernández, E., Glišić, M., Voortman, T., Ghanbari, M., Bramer, W. M., Chowdhury, R., Nijsten, T. E. C., Dehghan, A., Franco, O. H., et al. (2019) · International Journal of Inflammation · doi:10.1155/2019/6273680 · Cited by 51
“The gene SOCS3, suppressor of cytokine signalling 3, plays a pivotal role in the innate immune system as a regulator of cytokine signalling along the JAK/STAT pathway and was previously reported to have an important role in the processes of atherosclerosis [42].”
BackgroundAdaptive responses of histone modifications to resistance exercise in human skeletal muscle
Lim, C., Shimizu, J., Kawano, F., Kim, H. J., & Kim, C. K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231321 · Cited by 48
“Socs3 is reportedly induced by IL-6, but inhibits the IL-6-mediated JAK-STAT pathway, and suppresses inflammation [28].”
BackgroundIL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever
Flores-Mendoza, L. K., Estrada-Jiménez, T., Sedeño-Monge, V., Moreno, M., Manjarrez, M. D. C., González-Ochoa, G., Peña, L. M.-P., & Reyes‐Leyva, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/5197592 · Cited by 47
“Of the eight family members, socs1 and socs3 are the most potent inhibitors of cytokine signaling mediated by the JAK/STAT pathway [18, 19].”
BackgroundFaletti, L. E., Ehl, S. R., & Heeg, M. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.03.003 · Cited by 47
“Additionally, SOCS3 mediates the ubiquitination and subsequent proteasome degradation of other receptors, like the G-CSF and insulin receptor [36].”
BackgroundCDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks
Uras, I. Z., Maurer, B., Nivarthi, H., Jodl, P., Kollmann, K., Prchal‐Murphy, M., Feenstra, J. D. M., Zojer, M., Lagger, S., Grausenburger, R., et al. (2019) · Blood · doi:10.1182/blood-2018-08-872648 · Cited by 46
Targeting STAT3: A crucial modulator of sepsis
Lei, W., Liu, D., Sun, M., Lu, C., Yang, W., Wang, C., Cheng, Y., Zhang, M., Shen, M., Yang, Z. P., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30394 · Cited by 47
Alcaraz‐Quiles, J., Titos, E., Casulleras, M., Pavesi, M., López‐Vicario, C., Rius, B., Lopategi, A., Gottardi, A. D., Graziadei, I. W., Grønbæk, H., et al. (2016) · Hepatology · doi:10.1002/hep.28896 · Cited by 45
“We also assessed an SNP (rs1800871) in the gene coding for the antiinflammatory cytokine IL-10((10)) and an SNP (rs4969170) in the suppressor of cytokine signaling (SOCS) 3.((11)) The screening also included an SNP (rs3135500) coding for nucleotide-binding oligomerization domain-containing protein 2 (NOD2), a receptor…”
MethodMimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer
Manna, S. L., Lee, E.-M., Ouzounova, M., Natale, C. D., Novellino, E., Merlino, A., Körkaya, H., & Marasco, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31594 · Cited by 44
“The SOCS family proteins play crucial roles in these processes.(1) SOCSs are traditionally considered as negative feedback inhibitors of Janus Kinases-Signal Transducer and Activator of Transcription (JAK-STAT) pathway, but more recently, they have been shown to be regulated by different transcriptional, translational…”
BackgroundTargeting BRD9 for Cancer Treatment: A New Strategy
Zhu, X., Liao, Y., & Tang, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s286867 · Cited by 45
Feng, Y. M., Guo, S., Zhao, Y., Dong, H., Qian, J., Hu, Y., Wu, L., Jia, Y., & Zhao, R. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01130-3 · Cited by 46
“SOCS3 serves as a “brake” in the auto-regulatory feedback loop to prohibit nuclear translocation of STAT3 [31].”
BackgroundMiki, H., Pei, H., Gracias, D. T., Linden, J. M., & Croft, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.005 · Cited by 45
Kopalli, S. R., Prakash, A. V., & Koppula, S. (2022) · Molecules · doi:10.3390/molecules27144660 · Cited by 45
“The SOCS3 gene, cloned in 1997, is one of the major SOCS family proteins that have been shown to possess immunoregulatory roles in inflammatory-associated infections including AD [67,68].”
BackgroundHarwardt, T., Lukas, S., Zenger, M., Reitberger, T., Danzer, D., Theresa, Ü., Munday, D. C., Nevels, M. M., & Paulus, C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005748 · Cited by 43
“One of the pSTAT3 target genes encodes the suppressor of cytokine signaling 3 (SOCS3) which forms part of a negative feedback circuit by inhibiting IL6 signaling [8, 9].”
BackgroundBioengineered three-dimensional diseased intervertebral disc model revealed inflammatory crosstalk
Srivastava, A., Isa, I. L. M., Rooney, P., & Pandit, A. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.045 · Cited by 43
Sahini, N., & Borlak, J. (2016) · Translational Research: The Journal of Laboratory and Clinical Medicine · doi:10.1016/j.trsl.2016.06.003 · Cited by 47
Bayık, D., Tross, D., & Klinman, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00608 · Cited by 42
“org March 2018 | Volume 9 | Article 608 (SOCS3, Figure 6C) (40).”
A network of core and subtype-specific gene expression programs in myositis
Amici, D. R., Pinal‐Fernandez, I., Christopher‐Stine, L., Mammen, A. L., & Mendillo, M. L. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02365-5 · Cited by 39
“This approach successfully identified hubs with overarching control of their correlated process, such as the master regulators MYOG (myogenesis [4]) and SOCS3 (NFKB [8]) (Fig.”
BackgroundSpeth, J. M., Bourdonnay, E., Penke, L. R. K., Mancuso, P., Moore, B. B., Weinberg, J. B., & Peters-Golden, M. L. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502153 · Cited by 44
“As recent studies have implicated intracellular SOCS3 in the regulation of inflammation and infection (23, 24), we sought to investigate the effects of both viral and bacterial infection on extracellular SOCS3 secretion in the lung.”
BackgroundKels, M. J. T., Ng, E., Rumaih, Z. A., Pandey, P., Ruuls, S. R., Körner, H., Newsome, T. P., Chaudhri, G., & Karupiah, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004615117 · Cited by 43
Zhang, L., Zhang, L., Pan, Y., Gao, J., Xu, Y., Li, X., Tian, Z., Chen, H., & Wang, Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100683 · Cited by 40
“(SOCS3), a critical regulator of infection and inflammation (33).”
BackgroundLin, X., Yu, S., Ren, P., Sun, X., & Jin, M. (2019) · Cellular Microbiology · doi:10.1111/cmi.13150 · Cited by 40
“This led us to focus on SOCS1 and SOCS3, which were reported to be involved in the antiviral response (Alexander, 2002; Carow & Rottenberg, 2014; Pothlichet, Chignard, & Si-Tahar, 2008) .”
Background
Metadata
- Authors
- Carow, B., & Rottenberg, M. E.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Carow, Berit
- ORCID
- Carow, Berit
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 58-58
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC3928676
- OpenAlex
- W2140013858
- Cited by
- 555
- References
- 179
- Citations by year
- 2026: 31 · 2025: 55 · 2024: 65 · 2023: 71 · 2022: 64 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 31 · 2017: 25 · 2016: 27 · 2015: 24 · 2014: 9
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- SOCS3, suppressor of cytokine signaling, infection, inflammation, autoimmune disease, STAT3 activation, JAK kinases, cytokine signaling, receptor ubiquitination, proteasomal degradation, immune homeostasis, myeloid cells, lymphoid cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review